Evidence map›Paper›PMID 40421277›Full record

ArticleBiochemistry and biophysics reports2025

Porcine intestinal organoids cultured in an organ-on-a-chip microphysiological system.

James Bacon, Halie Kitchel, John Stutz, Jack Hua Chen, Aaron Smith, Robert D Van Horn, Christopher Moreland, Trent Abraham, Thomas Baker, Eitaro Aihara and 1 more

Abstract read
In one paragraph

Article in Biochemistry and biophysics reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Animal organoids as models for integrated One Health research.One health (Amsterdam, Netherlands) · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

James BaconEli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, 46285, USA.
Halie KitchelEli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, 46285, USA.
John StutzEli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, 46285, USA.
Jack Hua ChenEli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, 46285, USA.
Aaron SmithEli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, 46285, USA.
Robert D Van HornEli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, 46285, USA.
Christopher MorelandEli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, 46285, USA.
Trent AbrahamEli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, 46285, USA.
Thomas BakerEli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, 46285, USA.
Eitaro AiharaEli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, 46285, USA.
Kathleen HillgrenEli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, 46285, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Preclinical studies are a vital component of pharmaceutical development and improvements in the predictive value of in vitro studies are essential. Organ-on-a-chip in vitro models are a recent advancement in the pursuit of improved reproduction of in vivo tissue complexity. Here, we report the development and characterization of porcine intestinal cells from organoids on chips with microfluid dynamics and peristaltic-like strain in a microphysiological system. Intestinal epithelial cells were grown on a porous membrane as a co-culture with human intestinal microvascular endothelial cells for up to 12 days. These cultures formed villi-like structures and established a tight barrier replete with F-actin and tight junctions. A demarcated region of the epithelial cells was in an actively proliferative stage, reminiscent of intestinal crypts. The intestinal epithelial cell growth was characterized for the presence of enterocytes, goblet cells and enteroendocrine cells. Notable drug transporters and CYP450 metabolic activity were present in these cultures. The organoid chip maintained barrier function as the paracellular permeability was low. In contrast, the permeability enhancer, sodium caprate (C

Identifiers

PMID40421277
PMCPMC12104630

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.